curriculum vitae july 2007 joseph a. smith, … · - societe internationale d'urologie -...

CURRICULUM VITAE July 2007 JOSEPH A. SMITH, JR., M.D. PRESENT POSITION: William L. Bray Professor and Chairman

Department of Urologic Surgery Vanderbilt University School of Medicine Nashville, Tennessee

EDUCATION AND TRAINING: High School: Father Ryan High School, Nashville, Tennessee

September 1963-June 1967

College: University of Notre Dame, South Bend, Indiana September 1967-June 1968 University of Tennessee, Knoxville, Tennessee September 1968-June 1971 Bachelor of Science June 1971

Medical School: University of Tennessee, Memphis, Tennessee

September 1971-June 1974, M.D. June 1974

INTERNSHIP: Parkland Memorial Hospital, University of Texas, Southwestern Medical School, Dallas, Texas July 1974-June, 1975 SURGERY RESIDENCY: Parkland Memorial Hospital, University of Texas, Southwestern Medical School, Dallas, Texas July 1975-June 1976 UROLOGY RESIDENCY: University of Utah, Salt Lake City, Utah July 1976-June 1979 UROLOGIC ONCOLOGY FELLOW: Memorial Sloan-Kettering Cancer Center, New York, New York July 1979-June 1980 PROFESSIONAL EXPERIENCE: Assistant Professor of Surgery, July 1980-June 1983

Division of Urology, University of Utah Health Sciences Center, Salt Lake City, Utah

Associate Professor of Surgery, July 1983-June 1988 Division of Urology, University of Utah Health Sciences Center, Salt Lake City, Utah Professor of Surgery, July 1988-91 Division of Urology, University of Utah Health Sciences Center, Salt Lake City, Utah

William L. Bray Professor of Surgery and Chairman, July 1991-Present Department of Urologic Surgery, Vanderbilt University Medical Center Nashville, Tennessee

Vice-Chairman, Section of Surgical Sciences, July 1992-October 1993 Vanderbilt University Medical Center Nashville, Tennessee

Interim Chairman, Section of Surgical Sciences, 1993-1995 Vanderbilt University Medical Center Nashville, Tennessee

Associate Director, Section of Surgical Sciences, 2004-2006 Vanderbilt University Medical Center Nashville, Tennessee

PROFESSIONAL SOCIETIES: - American Medical Association

Residency Review Committee for Urology 1995-2001

Curriculum Vitae Joseph A. Smith, Jr., M.D.

Vice Chairman 1996 Chairman 1998-2000 - Fellow, American College of Surgeons Committee on Young Surgeons, 1986-92 Utah Representative, Cancer Committee, 1985-91 Utah Committee on Applicants, 1986-91 Tennessee Committee on Applicants, 1992, 1995 Program Director, Urology Section, 1993, 1998 - James Ewing Society of Surgical Oncology - American Board of Urology Examination Committee 1989-92 Oral Examiner 1993-present Trustee 1998-2005 President-Elect 2003-2004 President 2004-2005 - American Urological Association Program Committee, 1986, 1989, 1991-2005 Research Committee, 1986-91 Committee on Laser Use, 1987-present Chairman, Bladder Cancer Practice Parameters Committee, 1990-1998 Practice Parameters, Guidelines and Standards Committee, 1994-2002 Ultrasound Committee, 1993-1996 Urological Risk Management Committee 1998-2003 Chairman, EAU Fellow Committee 2003 Representative to ACS as Member, Board of Governors Alternate, 2004-Current Publication Committee 2003-2007 Chairman 2006-2007 - American Society Clinical Oncology Urology Scientific Program Director 2002 - American Society for Lasers in Medicine and Surgery Urology Chairman, 1983-85 - Utah Urologic Society President, 1981-83 - International Society for Laser Surgery - American Foundation for Urologic Disease Prostate Health Council Member, 1991-2003 Chairman, 1995-2003 - Southeastern Section, American Urologic Association Education Committee Member, 1995-1998 Tennessee Delegate 1995-1998 Secretary 2000-2003 President-Elect 2003-2004 President 2004-2005 - Societe Internationale d'Urologie - Eastern Cooperative Oncology Group Bladder Cancer Disease Chairman, 1992-1994 - TransAmerican Urological Research Group - Society of University Urologists Executive Committee 2001-2004 - American Association of Genitourinary Surgeons - American Association of Clinical Urologists - Society of Urologic Oncology Secretary, 1995-1998 President-elect 1999-2000 President 2001-2003 - Society for Basic Urologic Research - Western Urologic Forum - Nashville Surgical Society - H. William Scott Society - Vanderbilt Urology Society


- American Cancer Society National Detection and Treatment Advisory Group for Prostate Cancer 1994-present National Advisory Group on Detection Guidelines and Cancer Treatment Information, 1995-1998 - American Joint Commission on Cancer Cancer Staging Steering Committee, 1996 - Sigma Xi Scientific Research Society - Clinical Society of Genitourinary Surgeons - American College of Surgeons Oncology Group - Nashville Academy of Medicine - Tennessee Urologic Association President 1999-2001

HONORS AND AWARDS: - Notre Dame Scholar, 1968

- Alpha Omega Alpha Honor Society, University of Tennessee, 1974 - Outstanding Graduate Award, University of Tennessee College of Medicine, 1974 - Named one of ABest Doctors In America@ America Health Magazine March 1996 - Listed in The Best Doctors in America edited by Steven Naifoh, Gregory Smith, Aiken:Woodward White, Inc. - Listed annually in Best Doctors in America, Castle Connelly 1988-2007 - Named one of AThe Best 400 Doctors in American, Good Housekeeping - Listed as one of AThe Best Medical Specialists in North America@, Town and Country - Listed as one of the "Top Ten American Surgeons", US News and World Report - The University of Tennessee College of Medicine Outstanding Alumnus Award, 2003 - American Urological Association Distinguished Contribution Award, 2004 - Vanderbilt University nominee to Castle Connelly National Surgeon of the Year

Board Certified, Urology - February, 1981 HOSPITAL AFFILIATIONS: Vanderbilt University Hospital and Medical Center

Chairman, Department of Urologic Surgery Surgeon in Chief, 1993-1995 Medical Director of the Operating Room, 1993-1995 Nashville Veterans Affairs Hospital Consultant Nashville Metropolitan General Hospital Consultant St. Thomas Hospital, Nashville Courtesy Staff

UNIVERSITY SERVICE: - Vice-Chairman, Section of Surgical Sciences, 1992-1993

- Interim Chairman, Section of Surgical Sciences, 1993-1995 - Chairman, Department of Urologic Surgery, 1991-Present - Faculty Promotions, Retention and Tenure Committee1993-1995 - Medical School Promotions Committee, 1992-1994 - Operating Room Committee - Chairman, Search Committee for Department of Anesthesiology Chairman, 1993 - Member, Search Committee for Chairman of Department of Family Medicine, 1996 - Member Task Force on Administrative Infrastructure in Support of Clinical Practice, 1996 - Medical Director of the Operating Room, 1993-1995 - Vanderbilt Medical Group, Board of Directors, 1995-present - Chairman of Search Committee for Department of Plastic Surgery Chairman, 1996 - Chairman of Vice Chancellor=s Committee for Promotion and Tenure, 1996-98 - Consultant, Vanderbilt Athletic Department - Member, Task Force for Finance, Vanderbilt Medical Group

JOURNAL REVIEWER: - Journal of the American Medical Association

- Endourology


- Journal of Urology - Urology - Cancer - Prostate Cancer and Prostatic Diseases - Lasers in Surgery and Medicine - Journal of Clinical Oncology - Journal of Surgical Oncology - Journal of Clinical Outcomes in Medicine - Urologic Oncology - New England Journal of Medicine - Journal of Robotic Surgery

EDITORIAL EXPERIENCE: Journals - Assistant Editor, Journal of Urology, 1998-2006

- Associate Editor, Journal of Urology, 2006-current - Associate Editor, Investigative Urology, 1989-1992 - Associate Editor, Endourology, 1990-present - Associate Editor, Seminars in Urology, 1993, 1995 - Associate Editor, Seminars In Urologic Oncology, 1995-2003

- Associate Editor, Urologic Oncology Seminars and Original Contributions 2003-present - Editorial Board, Urological Survey, Journal of Urology, 1994-2006 - Editorial Board, Lasers in Surgery and Medicine, 1995-present - Editorial Board, Family Urology, 1995-2001 - Editorial Board, Prostate Cancer and Prostatic Diseases, 1995-present - Editorial Board, Primary Care Update, 1996-present - Editorial Board, Journal of Evaluation in Clinical Practice, 1997-present - Editorial Board, Current Urology Reports, 2000-present - Associate Editor, Journal of Robotic Surgery, 2006-Present - Editorial Committee, Journal of Urologic Oncology, 1998-2003

Books 1. Smith JA Jr, Editor. Lasers in Urologic Surgery. Chicago: Year Book Medical Publishers, 1985. 2. Smith JA Jr, Middleton RG, Editors. Clinical Management of Prostatic Cancer. Chicago: Year Book Medical, 1987. 3. Smith JA Jr, Stein BS, Benson RC, Editors. Lasers in Urologic Surgery (2nd edition). Chicago: Year Book Medical Publishers,

1989. 4. Smith JA Jr, Editor. Technologic Innovations in Urology. Philadelphia: W. B. Saunders, 1992. 5. Stein BS, Caldamone SA, and Smith JA Jr, Editors. Practice of Urology. New York: Norton Medical Publishers, 1992. 6. Smith JA Jr, Stein BS, and Benson RC, Editors. Lasers in Urologic Surgery (3rd edition). Chicago: Mosby Year Book Medical

Publishers, 1993. 7. Smith JA Jr, Associate Editor. Glenn's Urologic Surgery. J. B. Lippincott Company, Philadelphia, 1996. 8. Stein BS, Caldamone SA and Smith JA Jr, Editors. Practice of Urology (2nd Edition). New York: Norton Medical Publishers, 1995 9. Tewari AS and Smith JA Jr, Editors. Robotic Urological Surgery. Elsevier Medical Publishers, 2007 10. Smith JA Jr, Associate Editor. Hinman=s Atlas of Urologic Surgery. Elsevier Medical Publishers, 2008. Invited Guest Editor 1. Smith JA Jr, Editor. Technologic Advances in Urologic Surgery. Urologic Clinics of North America. Philadelphia, WB Saunders,

(August) 1986. 2. Smith JA Jr, Editor. Treatment of Advanced Prostatic Cancer. Seminars in Urology. Orlando, Grune and Stratton, 1988. 3. Smith JA Jr, Editor. Lasers in Urologic Surgery. Monographs in Urology. 1990. 4. Smith JA Jr, Editor. Lasers in Urology. Urology Grand Rounds. 1990. 5. Smith JA Jr, Editor. Detection, Diagnosis and Treatment of Localized Carcinoma of the Prostate. Urologic Clinics of North

America. Philadelphia, WB Saunders, 1990. 6. Smith JA Jr, Editor. Current Grading and Staging Systems: Their Clinical Value. Controversies in the Management of Prostate

Cancer. Philadelphia, Co. Med. Communications, 1991, Part 8. 7. Smith JA Jr, Editor. Controversial Areas in the Management of Prostate Cancer. Practical Cases in Urology. American Urologic

Association, Series 14, No. 3, p 1-121, 1992. 8. Smith JA Jr, Editor. Advances in Urologic Oncology. Seminars in Urology. 1993, Vol 11, Number 1. 9. Smith JA Jr, Editor. Current status of lasers in urologic surgery. AUA Update Series. 1993. 10. Smith JA Jr, Editor. Lasers in Urology. Practical Cases in Urology. American Urologic Association, 1993.


11. Milam DF, Smith JA Jr, Guest Editors. Laser Prostatectomy. Profiles in Urology. 1994. 12. Smith JA Jr, Editor. Stage T1C prostate cancer: What the patient needs to know. Seminars in Urologic Oncology, W. B. Saunders,

1995. 13. Smith JA Jr, Chang SS, Guest Editors. New Approaches in the Treatment of Advanced Prostate Cancer. Urologic Clinics of North

America. Philadelphia, WB Saunders, May, 2006. BIBLIOGRAPHY JOURNAL ARTICLES: 1. Smith JA Jr, Lee RE, Middleton RG: Hypertension in childhood from renal vein thrombosis. J Urol 122:389-390, 1979. 2. Smith JA Jr, Middleton RG: Neonatal adrenal hemorrhage. J Urol 122:674-677, 1979. 3. Smith JA Jr, Middleton RG: Surgical approach to large Müllerian duct cysts. Urology 14:44-46, 1979. 4. Smith JA Jr, Middleton RG: The use of fluorescein in radical inguinal lymphadenectomy. J Urol 122:754-756, 1979. 5. Smith JA Jr, Herr HW: Spontaneous regression of pulmonary metastases from transitional cell carcinoma. Cancer 46:1499-1502,

1980. 6 Smith JA Jr, Lee RE, Middleton RG: Ventriculoureteral shunt for hydrocephalus without nephrectomy. J Urol 123:224-226, 1980. 7. Smith JA Jr: Surgical management of localized prostatic cancer. West J Med 9:6, 1981. 8. Smith JA Jr, Whitmore WF Jr: Regional lymph node metastasis from bladder cancer. J Urol 126:591-593, 1981. 9. Smith JA Jr, Whitmore WF Jr: Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol 125:643-645,

1981. 10. Campbell CM, Smith JA Jr, Middleton RG: Plasmacytoma of the urethra. J Urol 127:986, 1982. 11. Middleton RG, Smith JA Jr: Radical prostatectomy for stage B2 prostate cancer. J Urol 127:702-703, 1982. 12. Smith JA Jr: Management of advanced non-seminomatous tumors of the testis: the American experience. Proc European Org for

Res Treat Can 3:28-32, 1982. 13. Smith JA Jr, Batata M, Grabstald H, Sogani PC, Herr H, Whitmore WF Jr. Preoperative irradiation and cystectomy for bladder

cancer: Cancer 49:869-873, 1982. 14. Warner B, Santen R, Demers L, Max D, Lohmar P, Smith J, Muss H, Resnick M, Globe M, Wettlaufer J, Eisenberger M, Block N:

Effects of [D/LEU6 DES-GLY-NH210, PRO-ETHYLAMIDE9]-GnRH (Leuprolide) on steroidogenesis when used to treat prostatic

carcinoma. J Androl 3:14, 1982. 15. Parfitt HE Jr, Smith JA Jr, Gliedman JB, Middleton RG: Accuracy of staging in A1 carcinoma of the prostate. Cancer 51:2346--

2350, 1983. 16. Parfitt HE Jr, Smith JA Jr, Seaman JP, Middleton RG: Surgical treatment of stage A2 prostatic carcinoma: significance of tumor

grade and extent. J Urol 129:763-765, 1983. 17. Smith JA Jr: Neodymium:YAG laser photoradiation of canine ureters: An analysis of penetration depth and subsequent healing.

Surg Forum 34:696-698, 1983. 18. Smith JA Jr, Dixon JA: Laser treatment of superficial bladder cancer. Observations on feasibility and efficacy. Lasers Med and

Surg 3:196-200, 1983. 19. Smith JA Jr, Herr HW, Middleton RG: Bladder carcinosarcoma: histologic variation in metastatic lesions. J Urol 129:829-831,

1983.


20. Smith JA Jr, Max DT: Clinical effects of a new GnRH analog in metastatic carcinoma of the prostate. Int Cong Chemo 242:1, 1983.

21. Smith JA Jr, Samson MK: Chemotherapy of testis cancer: a Southwest Oncology Group study of high vs. low dose cisplantin. Euro

Org for Res Treat Can 2:110-113, 1983. 22. Smith JA Jr, Seaman JP, Gleidman JB, Middleton RG. Pelvic lymph node metastasis from prostatic cancer: influence of tumor

grade and stage in 452 consecutive patients. J Urol 130:290-292, 1983. 23. Warner B, Worgul TJ, Drago J, Demers L, Dufau M, Max D, Santen RJ, Smith JA Jr and Members of the Abbott Study Group:

Effect of very high dose D-Leucine6-Gonadotropin-Releasing-Hormone proethylamide on the hypothalamic - pituitary testicular axis in patients with prostatic cancer. J Clin Invest 71:1842-53, 1983.

24. Garnick MB, Glode LM, Smith JA Jr, et al and The Leuprolide Study Group: Leuprolide versus Diethylstilbestrol for metastatic

prostate cancer. New Engl J Med 311:1281-1286, 1984. 25. Santen RJ, Demers LM, Max DT, Smith J, Stein BS, Glode LM: Long term effects of administration of a gonadotropin-releasing

hormone superagonist analog in men with prostatic carcinoma. J Clin Endocrin Metab 58(2):397-400, 1984. 26. Smith JA Jr: Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the

prostate. J Urol 131:1110-1112, 1984. 27. Smith JA Jr, Dixon JA: Argon laser phototherapy of superficial transitional cell carcinoma of the bladder. J Urol 131:655-656,

1984. 28. Smith JA Jr, Dixon JA: Laser photoradiation in urologic surgery. J Urol 131:631-635, 1984. 29. Smith JA Jr, Dixon JA: Neodymium:YAG laser irradiation of bladder hemangioma. Urology 24:134-136, 1984. 30. Smith JA Jr, Dixon JA: Neodymium:YAG laser treatment of benign urethral strictures. J Urol 131:1080-1081, 1984. 31. Smith JA Jr, Eyre HJ, Roberts TS, Middleton RG: Transphenoidal hypophysectomy in the management of carcinoma of the

prostate. Cancer 53:2385-2387, 1984. 32. Smith JA Jr, Haynes TH, Middleton RG: Impact of external irradiation on local symptoms and survival free of disease in patients

with pelvic lymph node metastasis from adenocarcinoma of the prostate. J Urol 131:705-707, 1984. 33. Smith JA Jr, Lee RG, Dixon JA: Tissue effects of Neodymium:YAG laser photoradiation of canine ureters. J Surg Oncol 27:168-

171, 1984. 34. Vance MA, Smith JA Jr: Endocrine and clinical effects of leuprolide in prostatic cancer. Clin Pharmacol Ther 36:350-354, 1984. 35. Al-Sarraf M, Frank J, Smith JA Jr, O'Bryan RM, Costanzi JJ, Stephens RL, Caraveo J, Crawford ED: Phase II trial of cyclo-

phosphamide, doxorubicin, and cisplatin versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: A Southwest Oncology Group study. Cancer Treat Rep 69:189-194, 1985.

36. Block NL, Garnick MB, Glode LM, Guinan PD, Sharifi R, Smith JA Jr: Preliminary evaluation of efficacy and safety of

gonadotropin-releasing hormone analogue (Leuprolide) in management of advanced adenocarcinoma of prostate. Urology (Suppl) 25:58-59, 1985.

37. Garnick MB, Glode LM, Smith JA Jr, Max DT: Leuprolide: A review of its effects in comparison with diethylstilboestrol in the

treatment of advanced cancer of the prostate. Br J Clin Pract 39:73-76, 1985. 38. Meikle AW, Smith JA Jr, West DW: Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate 6:121-

128, 1985. 39. Melzer RB, Wood TW, Landau ST, Smith JA Jr: Combination of CUSA and neodymium:YAG laser for canine partial

nephrectomy. J Urol 134:620-622, 1985. 40. Orton KR and Smith JA Jr: Simple renal cysts in children. J Pediatr Surg 20:543-546, 1985.


41. Smith JA Jr: Laser treatment of bladder cancer. Seminars in Urology 3:2-9, 1985. 42. Smith JA Jr, Glode LM, Wettlaufer JN, , Stein BS, Glass AG, Max DT, Anbar D, Jagst CL, Murphy GP: Clinical effects of a

gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate. Urology 25:106-114, 1985. 43. Smith JA Jr, Lundergan D, Lewis CA: Treatment of bladder tumors with a Nd:YAG laser. AORN J 42:586, 588, 590, 1985. 44. Smith JA Jr, Middleton RG: Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J Urol

133:617-619, 1985. 45. Smith JA Jr, Urry RL: Testicular histology after prolonged treatment with a gonadotropin-releasing hormone analogue. J Urol

133:612-614, 1985. 46. Stein BS, Smith JA Jr: DES lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma

of prostate. Urology 25:350-353, 1985. 47. Landau ST, Wood TW, Melzer RB, Lee RG, Smith JA Jr: Renal evaluation after CUSA plus Nd:YAG laser for partial

nephrectomy. Lasers Surg Med 6:146-149, 1986. 48. Middleton RG, Smith JA Jr, Melzer RB, Hamilton PE: Patient survival and local recurrence rate following radical prostatectomy for

prostatic carcinoma. J Urol 136:422-424, 1986. 49. Smith JA Jr: Endoscopic applications of laser energy. Urol Clin North Am 13(3):405-419, 1986. 50. Smith JA Jr: Experience with laser energy in urologic surgery. Bull NY Acad Med 62:273-281, 1986. 51. Smith JA Jr: Interactions between laser energy and body tissues. J Endourology 1:9-10, 1986. 52. Smith JA Jr: Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer: Clinical perspective.

Urology (Suppl) 27(1):9-15, 1986. 53. Smith JA Jr: Treatment of invasive bladder cancer with a Neodymium:YAG laser. J Urol 135:55-57, 1986. 54. Wood TW, Schumann GB, Smith JA Jr: Aspiration cytology in the diagnosis of prostatic cancer. Urology 26:188-184, 1986. 55. Crawford ED, Das S, Smith JA Jr: Preoperative radiation therapy in the treatment of bladder cancer. Urol Clin North Am 14:781-

787, 1987. 56. Glode LM, Smith JA Jr: Long-term suppression of luteinizing hormone, follicle-stimulating hormone, and testosterone by daily

administration of leuprolide. J Urol 137:57-60, 1987. 57. Jacobson GM, Smith JA Jr, Stewart JR: Postoperative radiation therapy for pathologic stage C prostate cancer. Int J Radiat Oncol

Biol Phys 13:1021-1024, 1987. 58. Landau ST, Wood TW, Smith JA Jr: Evaluation of sapphire tip Nd:YAG laser fibers in partial nephrectomy. Lasers Surg Med

7:426-428, 1987. 59. Meikle AW, Smith JA Jr, Stringham JD: Production, clearance and metabolism of testosterone in men with prostatic cancer. Pros-

tate 10:25-31, 1987. 60. Middleton RG, Smith JA, Moore MH, Urry RL: A 15-year followup of a nonmicrosurgical technique for vasovasostomy. J Urol

137:886-887, 1987. 61. Smith JA Jr: Advances in treatment of bladder cancer. Eur Urol 3:7-9, 1987. 62. Smith JA Jr: Condylomata acuminata. Current Ther GU Surg 129-131, 1987. 63. Smith JA Jr: Lasers in urology. West J Med 147:189-190, 1987.


64. Smith JA Jr. New methods of endocrine management of prostatic cancer. J Urol 137:1-10, 1987. 65. Labasky RF, Smith JA Jr: Management of pain and other symptoms of advanced prostatic cancer. Semin Urol 6:311-321, 1988. 66. Smith JA Jr: Adequacy of tumor staging in transitional cell carcinoma of the bladder. J Endourology 2:403-407, 1988. 67. Smith JA Jr: Benign and malignant diseases of the bladder: Indications for laser therapy. J Urol N 7(3):469-474, 1988. 68. Smith JA Jr: Hormonal therapy of prostate cancer: Current concepts and future prospects. Clin Ther 10:281-286, 1988. 69. Smith JA Jr: Laser treatment of urologic cancers. Semin Surg Oncol 4:68-70, 1988. 70. Smith JA Jr: Management of localized prostatic cancer. Semin Surg Oncol 3:62-66, 1988. 71. Smith JA Jr: Morbidity and complications of laser surgery. J Urol 7:412-416, 1988. 72. Smith JA Jr: Treatment of advanced carcinoma of the prostate. Semin Urol 4:247-249, 1988. 73 Smith JA Jr: Use of lasers in urologic surgery. Infect Urol l:90-96, 1988. 74. Smith JA Jr, Hernandez A: Endocrine therapy of prostatic cancer. Revisiones en Cancer 2:157-165, 1988. 75. Das SK, Crawford ED, Smith JA Jr: The role of integrated preoperative radiotherapy and radical cystectomy in the management of

invasive bladder cancer. Am Urol Assoc Update 7:6-7, 1989. 76. Lamm DL, Crissmann J, Blumenstein B, Crawford ED, Montie J, Scardino P, Grossman HB, Stanisic T, Smith J, Sullivan J,

Sarosdy M: Adriamycin versus BCG in superficial bladder cancer: A Southwest Oncology Group Study. Prog Clin Biol Res 310:263-270, 1989.

77. Meikle AW, Smith JA Jr, Stringham JD: Estradiol and testosterone metabolism and production in men with prostatic cancer. J

Steroid Biochem 33:19-24, 1989. 78. Smith JA Jr: Current clinical role of lasers in urologic surgery. Monogr Urol 10:37-47, 1989. 79. Smith JA Jr: Current concepts in laser treatment of bladder cancer. Prog Clin Biol Res 303:463-469, 1989. 80. Smith JA Jr: Laser treatment for urologic cancer. Problems in Urology 3:473-485, 1989. 81. Smith JA Jr: Laser treatment in urology. Am Urol Assoc Update 13:98-103, 1989. 82. Smith JA Jr: Laser treatment of urologic cancers. Semin Surg Oncol 5:30-37, 1989. 83. Smith JA Jr: Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized,

prospective, double-blind, placebo-controlled study. J Urol 141:85-87, 1989. 84. Smith JA Jr: Patient selection for radical prostatectomy. Urology 33(5 Suppl):17-20, 1989. 85. Smith JA Jr: Treatment of benign urethral strictures using a sapphire tipped neodymium:YAG laser. J Urol 142:1221-1222, 1989. 86. Smith JA Jr: Treatment of localized prostatic cancer. Semin Surg Oncol 5:240-246, 1989. 87. Smith JA Jr, Dixon JA: Treatment of recurrent bleeding from benign hemangioma of the bladder. Clin Diag 37:36-37, 1989. 88. Smith JA Jr, Landau S: Neodymium:YAG laser specifications for safe intravesical therapy. J Urol 141:1238-1239, 1989. 89. Smith JA Jr, Middleton RG: Extracorporeal piezolithotripsy: Observations on anesthetic requirement during treatment. J

Lithotripsy Stone Dis 1:119-121, 1989. 90. Stone NN, Kongrad A, Chodak GW, Ray PS, Smith JA Jr, Scardino PT, Paulsen DF, and Neri RO: A double-blind randomized

controlled study of the effect of flutamide in benign prostatic hypertrophy: clinical efficacy. Urol Res 17:338-348, 1989.


91. Crawford ED, Kasimis BS, Gandara D, Smith JA Jr, Soloway MS, Lange PH: A randomized controlled study of leuprolide and anandron versus leuprolide and placebo for advanced prostate cancer. J Clin Oncol 9:135, 1990.

92. Hernandez AD, Smith JA Jr: Transrectal ultrasonography for the early detection and staging of prostate cancer. Urol Clin North

Am 17:745-757, 1990. 93. Hernandez AD, Smith JA Jr, Jeppson KG, Terreros DA: A controlled study of the argon beam coagulator for partial nephrectomy.

J Urol 143:1062-1065, 1990. 94. Hernandez AD, Urry RL, Smith JA Jr: Ultrasonographic characteristics of the seminal vesicles after ejaculation. J Urol 144:1380-

1382, 1990. 95. Meikle AW, Smith JA Jr: Epidemiology of prostate cancer. Urol Clin North Am 17:709-718, 1990. 96. Smith JA Jr: Laser treatment of bladder hemangioma. J Urol l43:282-284, 1990. 97. Smith JA Jr: Management of patients with stage A1 adenocarcinoma of the prostate. Controversies in the Management of Prostate

Cancer 1:4-7, 1990. 98. Smith JA Jr: Targeting the laser to urologic surgery. Contemporary Urology 4:13-22, 1990. 99. Smith JA Jr, Cho YH: Management of stage A prostate cancer. Urol Clin North Am 17:769-777, 1990. 100. Chodak GW, Vogelzang J, Caplan RJ, Soloway M, Smith JA Jr: Independent prognostic factors in patients with metastatic (stage

D2) prostate cancer. JAMA 265:618-621, 1991. 101. Cope RM, Middleton RG, Smith JA Jr: A 2-year experience with the Wolf piezoelectric lithotripter: impact of repeat treatment on

results and complications. J Urol 145:1141-1144; Discussion 1144-1145, 1991. 102. Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA Jr, Sullivan J, Sarosdy

MF, Coltman CA: A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 325:1205-1209, 1991.

103. Smith JA Jr: Application of laser energy in urologic surgery. Surg Annu 23(Part 2):81-97, 1991. 104. Smith JA Jr: Laser treatment of the urethra and prostate. Semin Urol 9:180-184, 1991. 105. Smith JA Jr, Hernandez AD, Wittwer CJ, Avent JM, Greenwood J, Hammond EH, Middleton RG: Long-term follow-up after

radical prostatectomy: Identification of prognostic variables. Urol Clin North Am 18:473-476, 1991. 106. Soloway MS, Chodak G, Vogelzang NJ, Block NL, Schellhammer PF, Smith JA Jr, Scott M, Kennealey G, Gau TC: Zoladex

versus orchiectomy in treatment of advanced prostate cancer: A randomized trial. Urology 37:46-51, 1991. 107. Stone NN, Ray PS, Smith JA Jr, Scardino PT, Smith RB, Khanna OP, Paulson DF: Ultrasound determination of prostate volume: a

comparison of transrectal (ellipsoid versus planimetry) and suprapubic methods. J Endourol 251-254, 1991. 108. Cho YH, Chi SH, Hernandez AD, Unluer E, Smith JA Jr: Adriamycin absorption after Nd:YAG laser coagulation compared to

electrosurgical resection of the bladder wall. J Urol 147:1139-1141, 1992. 109. Cho YH, Straight RC, Smith JA Jr: Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder

tumor model. J Urol 147:743-746, 1992. 110. McWhorter WP, Hernandez AD, Meikle AW, Terreros DA, Smith JA Jr, Skolnick MH, Cannon-Albright LA, Eyre HJ: A screening

study of prostate cancer in high risk families. J Urol 148:826-828, 1992. 111. Schellhammer P, Debruyne F, Altwein J, Ambrose S, Jones G, Schmidt J, Smith J, Zincke H: Prostate Cancer-Locoregional disease.

Cancer 70:362-364, 1992. 112. Smith JA Jr: Anterior extraperitoneal approach for living donor nephrectomy. Cont Urology 4:12-16, 1992.


113. Smith JA Jr: Laser surgery for transitional-cell carcinoma. Technique, advantages, and limitations. Urol Clin North Am 19:473-483, 1992.

114. Smith JA Jr: Management of localized prostate cancer. Cancer 70:302-306, 1992. 115. Matzkin H, Soloway MS, Schellhammer PF, Chodak G, Smith JA, Caplan R, Kennealey GT: Prognostic factors in stage D2

prostate cancer treated with a pure nonsteroidal antiandrogen. Cancer 72:1286-1290, 1993. 116. McCullough DL, Roth RA, Babayan RK, Gordon JO, Reese JH, Crawford ED, Fuselier HA, Smith JA, Murchison RJ, Kaye KW:

Transurethral ultrasound-guided laser-induced prostatectomy: National Human Cooperative Study results. J Urol 150:1607-1611, 1993.

117. Scaletscky R and Smith JA: Disease flare with gonadotrophin-releasing hormone (GnRH) analogues: How serious is it? Drug

Safety 8(4):265-270, 1993. 118. Smith JA Jr: Review: tissue effects of laser energy. J Endourol 7(5):389-390, 1993. 119. Smith JA Jr and Scaletscky R: Future directions in tumor marker technology for prostate cancer. Urol Clin N Amer 20(4):771-777,

1993. 120. Smith JA Jr: Physics and tissue effects of laser. J Urol 152:317-319, 1994. 121. Smith JA Jr: Surgical results in continent urinary diversion and orthotopic bladder replacement. Semin Urol 11:20-23, 1993. 122. Koch MO, Brandell RA, Lin D, Smith JA Jr: The effect of sequential compression devices on intraoperative blood loss during

radical prostatectomy. J Urol 152:1178-1179, 1994. 123. Koch MO, Smith JA Jr: Local recurrence of squamous cell carcinoma of the penis. Urol Clin N Amer 21:739-743, 1994. 124. Koch MO, Smith JA Jr, Hodge EM, Brandell RA: Prospective development of a cost-efficient program for radical retropubic

prostatectomy. Urology 44:311-318, 1994. 125. Robertson JB, Koch MO, Kirchner FK Jr, and Smith JA Jr: Suboptimal treatment results with the Therasonics lithotripter. J Urol

152:317-319, 1994. 126. Scaletscky R, Koch MO, Eckstein CW, Bicknell SL, Gray GF Jr, and Smith JA Jr: Tumor volume and stage in carcinoma of the

prostate detected by elevations in prostate specific antigen. J Urol 152:129-131, 1994. 127. Scaletscky R, Wright JK Jr, Shaw J, and Smith JA Jr: Ileal conduit venous varices from portal hypertension as a cause of recurrent,

massive hemorrhage. J Urol 151:417-419, 1994. 128. Smith JA Jr: A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the

prostate. J Urol 152:132-134, 1994. 129. Smith JA Jr: Current concepts in the treatment of cancer of the prostate. Am Cancer Soc Newsletter 22:2, 1994. 130. Smith JA Jr: Editorial: Prostate cancer: If we only had more data. J Urol 152:135, 1994. 131. Hall MC, Koch MO, and Smith JA Jr: Femoral neuropathy complicating urologic abdominopelvic procedures. Urology 45:146-

149, 1995. 132. Andriole G, Lieber M, Smith JA Jr, Soloway MS, et al: Treatment with finasteride following radical prostatectomy for prostate

cancer. Urology 45:491-497, 1995. 133. Koch MO, Smith JA Jr: Clinical outcomes associated with the implementation of a cost efficient programme for radical retropubic

prostatectomy. Brit J Urol 76:28-33, 1995. 134. Smith JA Jr: Editorial: How can the desired tissue effects for laser treatment of the prostate best be achieved? J Urol 153:2, 1995.


135. Smith JA Jr: The role of prostate specific antigen in detection and treatment of prostate cancer. J Clin Outcomes Management 2:45-49, 1995.

136. Smith JA Jr: Stage T1c Prostate Cancer: Perspectives on Clinical Management. Semin Urol Oncol 1:238-244, 1995. 137. Koch MO, Seckin, B., Smith JA Jr: Impact of a collaborative care approach to radical cystectomy and urinary reconstruction. J

Urol 154:996-1001, 1995. 138. Lamm DL, Blumenstein B, Crissman JD, Crawford ED, Lowe BA, Smith JA Jr, Sarosdy MF, Schellhammer PF, Sagalowsky AI,

Messing EM: Randomized intergroup comparison of Bacillus Calmette-Guerin immunotherapy and Mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder. Urol Oncol 1:119-126, 1995.

139. Soloway MS, Schellhammer PF, Smith JA Jr, Chodak GW, Vogelzang NJ: Bicalutamide in the treatment of advanced prostate

carcinoma: a Phase II noncomparative trial evaluating safety, efficacy, and long-term endocrine effect of monotherapy. J Urol 154:2110-2114, 1995.

140. Koch MO and Smith JA Jr: Cost-containment in Urology. Urology 46:14-26, 1995. 141. Smith JA: Commentary on the desired tissue effects for laser treatment of the prostate and how they can best be achieved? J Uro

153:2, 1995. 142. Milam DF, Smith JA Jr: Laser prostatectomy devices and their tissue effects. J Endourol 9:85-88, 1995. 143. Vogelzang NJ, Chodak GW, Soloway MS, Block NL, Schellhammer PF, Smith JA Jr, Caplan RJ, Kennealey GT: Goserelin versus

orchiectomy in the treatment of advanced prostate cancer: final report of a randomized trial. Urology 46:220-226, 1995. 144. Koch MO and Smith JA Jr: Influence of patient age and comorbidity on outcome of a collaborative care pathway after radical

prostatectomy and cystoprostatectomy. J Urol 155:1681-1684, 1996. 145. Gerber GS, Thisted RA, Scardino PT, Frohmuller HG, Schroeder FH, Paulsen DF, Middleton AW, Smith JA Jr, Schellhammer PF,

and Chodak GW: Results of radical prostatectomy in men with clinically localized prostate cancer: Multi-institutional pooled analysis. JAMA 276:615-619, 1996.

146. Koch MO and Smith JA Jr: Blood loss during radical retropubic prostatectomy: Is preoperative autologous blood donation

indicated? J Urol 156:1079-1080, 1996. 147. Smith JA Jr: Asymptomatic microscopic hematuria in a 63 year old woman. J Clin Outcomes 32:24-40, 1996. 148. Soloway MS, Schellhammer PF, Smith JA Jr, Chodak GW: Bicalutamide in the treatment of advanced prostatic cancer: A phase II

multicenter trial. Urology 47:33-37, 1996. 149. Smith JA Jr: Asymptomatic microhematuria. Hospital Physician 32:24-40, 1996. 150. Smith JA Jr, Koch MO: Collaborative care pathways: impact on treatment costs and quality of care. Urology International 3:10-11,

1996. 151. Smith JA Jr: Transrectal ultrasonography for the detection and staging of carcinoma of the prostate. J Clin Ultrasound 24:455-461,

1996. 152. de Vere White RW, Deitch AA, Tesluk H, Blumenstein B, Lowe BA, Sagalowsky AI, Smith JA Jr, Schellhammer PF, Stanisic TH,

Grossman HB, Messing E: The prognostic significance of DNA ploidy in Ta/T1 bladder cancer: A Southwest Oncology Group Study. Urol Onc 2:27-34, 1996

153. Smith JA Jr.: Management of hot flushes due to endocrine therapy of prostate cancer. Oncology 10:1319-1324, 1996. 154. Koch MO, Smith JA Jr.: Same day surgery for radical retropubic prostatectomy: is it an attainable goal? Urology 48:660-661, 1996. 155. Smith, JA Jr: What is watchful waiting and why is it considered to be a treatment option for prostate cancer? Family Urology

Summer:13, 1996


156. Koch MO, Smith JA Jr: Cost efficient management of the patient with localized prostate cancer. AUA Update Series 16:122-127, 1997.

157. Smith JA Jr, Crawford ED, Blumenstein B, Samlowski W, Grossman HB, Christie DW: Treatment of advanced bladder cancer with

combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: A Phase III Intergroup Study. J Urol 157:805-808, 1997.

158. Smith JA Jr, Scardino PT, Resnick MI, Hernandez AD, Rose SC, and Egger MJ: Transrectal ultrasound versus digital rectal

examination for the staging of carcinoma of the prostate: Results of a prospective, multi-institutional trial. J Urol 157:902-906, 1997.

159. Smith JA Jr, Lange, PH, Janknegt RA, Abbou CC, deGery A: Serum markers as a predicting response duration and patient survival

after hormonal therapy for metastatic carcinoma of the prostate. J Urol 157:1329-1334, 1997. 160. Smith JA Jr, Janknegt R, Abbou CC, de Gery, A: Effect of androgen deprivation therapy on local symptoms and tumor progression

in men with metastatic carcinoma of the prostate. Euro Urol 31Suppl:25-29, 1997. 161. Smith JA Jr: Preoperative irradiation and cystectomy for bladder cancer. Sem Urol Onc 15:86-95, 1997. 162. Smith JA Jr: Surgical management of superficial bladder cancer (stages Ta/T1/CIS). Sem Surg Onc 13:328-334, 1997. 163. Koch MO, Smith JA Jr: Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects.

Prostate Cancer and Prostatic Diseases 1:101-104, 1997. 164. Gerber GS, Thisted RA, Chodak GW, Schroder FH, Frohmuller HG, Scardino PT, Paulsen DF, Middleton AW Jr, Rukstalis DB,

Smith JA Jr, Ohori M, Theiss M, Schellhammer PF: Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 32:385-390, 1997.

165. Smith JA Jr. Prostate cancerBresearch versus clinical patient management J Urol 157:575, 1997. 166. Resnick MI, Smith JA Jr., Scardino PT, Egger MJ, Hernandez A, Rose SC: Transrectal prostate ultrasonography-variability of

interpretation. J Urol 158:856-860, 1997. 167. Smith JA Jr, Fowler JE Jr, Ghoneim MA: Summary of preoperative irradiation and cystectomy for bladder cancer. Sem Urol Onc

15:86-93, 1997. 168. Smith JA Jr: Radical prostatectomy or radiation therapy for early prostate cancer. Contemp Urol 9:60-72, 1997. 169. Smith JA Jr, Koch MO: Collaborative care pathways: impact on treatment costs and quality of care after radical prostatectomy. J

Managed Care 1:36-38, 1997. 170. Koch MO, Miller DA, Butler R, Lebos L, Collings D, Smith JA Jr: Are we selecting the right patients for treatment of localized

prostate cancer? Results of an actuarial analysis. Urol 51:197-202, 1998. 171. Sharifi R, Knoll LD, Smith JA Jr, Kramolowsky E: Leoprolide acetate (30-mg depot every four months) in the treatment of

advanced prostate cancer. Urology 51:271-276, 1998. 172. Smith JA Jr, Crawford ED, Paradelo JC, Blumenstein B, Grossman HB, Christie DW: Treatment of locally advanced carcinoma of

the urinary bladder with preoperative radiotherapy and radical cystectomy versus radical cystectomy alone. [German] Urologe - Ausgabe A. 37:532-533, 1998.

173. Waters WB, Bassi P, Ohi Y, Ohshima S, van Poppel HPAM, Smith JA Jr, Tajima A: The role of pelvic lymph node dissection in the

management of invasive bladder cancer. Urologic Oncology 4:168-171, 1998. 174. Smith JA Jr, Labasky RF, Cockett AT, Fracchia JA, Montie JE, Rowland RG: Bladder cancer clinical guidelines panel summary

report on the management of nonmuscle invasive bladder cancer (Stages T1, T1, and TIS). J Urol 162:1697-1702, 1999. 175. Ead DN, Koch M, Smith JA Jr: Is invasive anesthetic monitoring necessary during radical prostatectomy? Prostatic Cancer and

Prostatic Diseases 2:282-284, 1999.


176. Smith JA Jr: Patients with superficial transitional cell carcinoma of the bladder and their smoking status. Cancer 86:2192-2194, 1999.

177. Smith JA Jr, Soloway MS, Young MJ: Complications of advanced prostate cancer. Urol 54(6A):8-14, 1999. 178. Darouiche RO, Smith JA Jr, Hanna H, Dhabuwala CG, et al.: Efficacy of antimicrobial-impregnated bladder catheters in reducing

catheter-associated bacteriuria: a prospective, randomized multicenter clinical trial. Urol 54:976-981, 1999. 179. Parekh DJ, Smith JA Jr.: Continent orthotopic urinary reconstruction after cystectomy. Contemporary Urology 11:55-60, 1999. 180. Bishoff JT, Gill IS, Marshall FF, Schulam PG, Smith, JA Jr: The role of laparoscopy in genitourinary malignancies, part 1.

Contemporary Urology 12:23-34, 2000. 181. Bishoff JT, Gill IS, Marshall FF, Schulam PG, Smith, JA Jr: The role of laparoscopy in genitourinary malignancies, part 2.

Contemporary Urology 12:28-49, 2000. 182. Holzbeierlein JM, Smith, JA: Radical prostatectomy and collaborative care pathways. Sem Urol Onc 18:60-65, 2000. 183. DeVere White RW, Deitch AD, Daneshmand S, Blumenstein B, Lowe BA, Sogalowsky AI, Smith JA Jr.Schellhammer PF, Stanisic

TH, Grossman HB, Messing E, Crissman JE, Crawford ED: The prognostic significance of S-phase analysis in Stage Ta/T1 bladder cancer: A Southwest Oncology Group Study. Euro Urology 37:595-600, 2000.

184. Gilbert WB, Smith JA Jr: Blood use strategies in urologic surgery. [Review]. Urol 55:461-467, 2000. 185. Grossklaus DJ, Holzbeierlein JM, Roth BJ, Smith JA Jr: Abnormal mammogram as the presenting sign of renal cell carcinoma. J of

Urol 163:1239-1240, 2000. 186. Holzbeierlein JM, Smith JA Jr: Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS). [Review]. Urology Clinics

of North America 27:15-24, 2000. 187. Parekh DJ, Gilbert WB, Smith JA Jr: Functional lower urinary tract voiding outcomes after cystectomy and orthotopic neobladder.

J of Urol 163:56-59, 2000. 188. Franke JJ, Gilbert WB, Grier J, Koch MO, Shyr Y, Smith JA Jr: Early post-prostatectomy pelvic floor biofeedback. J Urol 163:191-

193, 2000. 189. Parekh DJ, Gilbert WB, Koch MO, Smith JA: Continent urinary reconstruction versus ileal conduit: a contemporary single-

institution comparison of perioperative morbidity and mortality. Urol 55:852-855, 2000. 190. Smith JA Jr: Treating bladder cancer. Coping with Cancer 14:54-55, 2000. 191. Smith JA Jr: Indications for orthotopic bladder replacement increasingly liberal. Urology Times 28:1, 2000. 192. Smith, JA Jr: Techniques to decrease morbidity with radical prostatectomy. AUA Update Series 19:273-280, 2000. 193. Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA Jr, Shappell, SB: Reduced 15-lipoxygenase-2 immunostaining in

prostate adenocarcinoma: Correlation with grade and expression in high grade prostatic intraepithelial neoplasia. Hum Pathol 31:1146-1154, 2000.

194. Cookson MS, Smith JA Jr. PSA testing: update on diagnostic tools. Consultant 40:670-676, 2000. 195. Cookson MS, Smith JA Jr. PSA testing: to screen or not to screen. Consultant 40:678-680, 2000 196. Chang SS, Peterson M, Smith JA Jr. Intraoperative nerve stimulation predicts postoperative potency. Urology 58:594-597, 2001. 197. Holzbeierlein J, Peterson M, Smith JA Jr: Variability of results of cavernous nerve stimulation during radical prostatectomy. J Urol

165:108-110, 2001 198. Grossklaus DJ, Shappell SB, Gautam S, Smith JA Jr, Cookson MS: Ratio of fee-to-total prostate specific antigen correlates with

tumor volume in patients with increased prostate specific antigen. J Urol 165:455-458, 2001.


199. Pietrow PK, Smith JA Jr: Laser treatment for invasive and noninvasive carcinoma of the bladder. J Endourol 15:415-418, 2001. 200. Pietrow PK, Parekh DJ, Smith JA, Shyr Y, Cookson MS: Health related quality of life assessment after radical prostatectomy in men

with prostate specific antigen-only recurrence. J Urol 166:2286-2290, 2001. 201. Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang S, Cookson MS: Clinical under staging in high-risk non-muscle invasive

urothelial carcinoma treated with radical cystectomy. J Urol 166:490-493, 2001. 202. Chang SS, Alberts G, Cookson MS, Smith JA Jr: Radical cystectomy is safe in elderly patients at high risk. J Urol 166:938-941,

2001. 203. Chang SS, Smith JA Jr, Wells N, Peterson M, Kovach B, Cookson MS: Estimated blood loss and transfusion requirements of radical

cystectomy. J Urol 166:2151-2154, 2001. 204. Chang SS, Alberts G, Wells N, Smith JA Jr, Cookson MS: Intrarectal lidocaine during transrectal prostate biopsy: results of a

prospective double-blind randomized trial. J Urol 166:2178-2180, 2001. 205. Smith JA Jr, Milam DF. How I manage post-prostatectomy urinary incontinence. AUA News 7:15-16, 2002. 206. Chang SS, Baumgartner RG, Wells N, Cookson MS, Smith JA Jr: Causes of increased hospital stay after radical cystectomy in a

clinical pathway setting. J Urol 167:208-211, 2002. 207. Smith JA Jr: Informed choice in cancer screening. J Urol 167:422, 2002. 208. Nixon RG, Chang SS, LaFleur BJ, Smith JA Jr, Cookson MS: Carcinoma in situ and tumor multifocality predict the risk of prostatic

urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 167:502-505, 2002. 209. Chang SS, Cookson MS, Hassan JM, Wells N, Smith JA Jr: Routine postoperative intensive care monitoring is not necessary after

radical cystectomy. J Urol 167:1321-1324, 2002. 210. Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA Jr: Analysis of early complications after radical cystectomy: results

of a collaborative care pathway. J Urol 167:2012-2016, 2002 211. Chang SS, Cole E, Smith JA Jr, Cookson MS. Pathological findings of gynecologic organs obtained at female radical cystectomy. J

Urol 168:147-149, 2002. 212. Chang SS, Smith JA, Jr, Girasole C, Baumgartner RG, Roth BJ, Cookson MS: Beneficial impact of a clinical care pathway in

patients with testicular cancer undergoing retroperitoneal lymph node dissection. J Urol 168:87-92, 2002. 213. Dutta SC, Chang SS, Coffey CS, Smith JA Jr., Jack G, Cookson, MS: Health related quality of life assessment after radical

cystectomy comparison of ileal conduit with continent orthotopic neobladder. J Urol 168:164-167, 2002. 214. Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA Jr., Shappell SB: Pathological parameters of radical

prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. J Urol 168:519-524, 2002.

215. Chang SS, Cole E, Cookson MS, Peterson M, Smith JA Jr: Preservation of the anterior vaginal wall during female radical

cystectomy with orthotopic urinary diversion: technique and results. J Urol 168:1442-1445, 2002. 216. Smith JA, Nixon R, Bueschen AJ, Venable DD, Henry HH: The impact of blinded versus unblinded abstract review on scientific

program content. J Urol 168:2123-2125, 2002. 217. Smith JA Jr, Parekh DJ, O=Connor J, Jung C: Orthotopic neobladder following radical cystectomy in patients with high perioperative

risk and co-morbid medical conditions. J Urol 168:2454-2456, 2002. 218. Grossklaus DJ. Smith JA Jr. Shappell SB. Coffey CS. Chang SS. Cookson MS. The free/total prostate-specific antigen ratio

(%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. Urologic Oncology. 7:195-198, 2002.

219. Smith JA. Reconstruction of the Urinary Tract After Bladder Removal. Family Urology 7:14-17, 2002.


220. Baumgartner RG. Wells N. Chang SS. Cookson MS. Smith JA Jr.Causes of increased length of stay following radical cystectomy

Urologic Nursing. 22:319-323, 2002. 221. Smith JA Jr. Outcome after radical prostatectomy depends on surgical technique but not approach. Current Urology Reports.

3:179-181, 2002. 222. Dutta SC. Chang SC. Coffey CS. Smith JA Jr. Jack G. Cookson MS. Health related quality of life assessment after radical

cystectomy: comparison of ileal conduit with continent orthotopic neobladder J Urol. 168:164-167, 2002. 223. Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak W. Attitudes and use of

complementary medicine in men with prostate cancer. J Urol 168, 2505-2509, 2002. 224. Adkins KL. Chang SS. Cookson MS. Smith JA Jr. Partial nephrectomy safely preserves renal function in patients with a solitary

kidney. J Urol. 169:79-81, 2003. 225. Cookson MS, Chang SS, Wells N, Parekh D, Smith JA Jr: Complications of radical cystectomy for nonmuscle invasive disease:

comparison with invasive disease. J Urol 169:101-104, 2003. 226. Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER, Wells N, Smith JA Jr: Randomized prospective evaluation of extended

versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169:145-147, 2003. 227. Chang SS. Smith JA Jr. Cookson MS. Decreasing blood loss in patients treated with radical cystectomy: a prospective randomized

trial using a new stapling device. J Urol. 169:951-954, 2003. 228. Smith JA Jr. Editorial: sexual function after radical prostatectomy. J Urol. 169:1465, 2003. 229. Parekh DJ, Jung C, Roberts R, Shappell S, Smith JA Jr: Primary neuroendocrine carcinoma of the urethra. Urology 60:1111, 2002. 230. Chang SS. Hassan JM. Cookson MS. Wells N. Smith JA Jr. Delaying radical cystectomy for muscle invasive bladder cancer

results in worse pathological stage. J Urology. 170:1085-1087, 2003. 231. Cookson MS. Dutta SC. Chang SS. Clark T. Smith JA Jr. Wells N. Health related quality of life in patients treated with radical

cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urology. 170:1926-30, 2003.

232. Baldwin DD. Dunbar JA. Parekh DJ. Wells N. Shuford MD. Cookson MS. Smith JA Jr. Herrell SD. Chang SS. McDougall

EM. Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk. J Endourol. 17:161-167, 2003.

233. McConnell JD. Roehrborn CG. Bautista OM. Andriole GL Jr. Dixon CM. Kusek JW. Lepor H. McVary KT. Nyberg LM Jr.

Clarke HS. Crawford ED. Diokno A. Foley JP. Foster HE. Jacobs SC. Kaplan SA. Kreder KJ. Lieber MM. Lucia MS. Miller GJ. Menon M. Milam DF. Ramsdell JW. Schenkman NS. Slawin KM. Smith JA. Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.. NEJM. 349:2387-98, 2003.

234. Smith JA Jr. Robotically assisted laparoscopic prostatectomy: an assessment of its contemporary role in the surgical management of

localized prostate cancer. Am J of Surg 188(Suppl):63S-67S, 2004. 235. Herr HW, Smith JA Jr, Montie JE. Standardization of radical cystectomy: time to count and be counted. BJU Int 94:481-482, 2004. 236. Smith J. Preservation of the anterior vaginal wall during radical cystectomy. Contemp Urol 16:65-68, 2004. 237. Smith JA Jr, Cookson MS, Hall MC, Keane TE, Pruthi RS. Postsurgery PSA levels (Symposium) Contemp Urol 16:34-46, 2004. 238. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB. Incidence and location of prostate and urothelial

carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171:646-651, 2004. 239. Chang SS, Smith, Jr. JA, Jacobs B, Wells N, Cookson MS. Increased body mass index (BMI) predicts increased blood loss during

radical cystectomy, J Urol 171:1077-1079, 2004.


240. Herr H, Lee C, Chang S, Lerner S, Bladder Cancer Collaborative Group. Standardization of radical cystectomy and pelvic lymph

node dissection for bladder cancer: A collaborative group report. J Urol 171:1823-1828, 2004. 241. Chang SS, Duong DT, Wells N, Cole EE, Smith JA, Jr., Cookson MS. Predicting blood loss and transfusion requirements during

radical prostatectomy: the significant negative impact of increasing body mass index (BMI). J Urol, 171:1861-1865, 2004. 242. Kasper S, Smith JA Jr. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. J Urol

172:12-19, 2004. 243. Shuford MD, Cookson MS, Chang SS, Shintani AK, Tsiatis A, Smith JA Jr, Shappell SB. Adverse Prognostic significance of

capsular incision with radical retropubic prostatectomy. J Urol 172:119-123, 2004. 244. Nelson BA, Cookson MS, Smith JA Jr, Chang SS. Complications of inguinal and pelvic lymphadenectomy for squamous cell

carcinoma of the penis: a contemporary series. J Urol 172:494-497, 2004. 245. Hassan JM, Cookson MS, Smith JA Jr, Johnson DL, Chang SS. Outcomes in patients with pathological carcinoma in situ only

disease at radical cystectomy. J Urol 172:882-884, 2004. 246. Hassan JM, Cookson MS, Smith JA Jr, Chang SS. Urethral recurrence in patients following orthotopic urinary diversion. J Urol

172:1338-1341, 2004. 247. Smith JA Jr.: Techniques in endourology. Extraperitoneal standard laparoscopic radical prostatectomy [comment]. Urology 18:605-

10, 2004. 248. Montie JE, Smith JA Jr. Whitmoreisms: memorable quotes from Willet F. Whitmore, Jr., M.D. Urol 63:207-209, 207-209, 2004. 249. Shuford MD, McDougall EM, Chang SS, LaFleur BJ, Smith JA Jr, Cookson MS. Complications of contemporary radical

nephrectomy: comparison of open vs. laparoscopic approach. Urol Onc 22:121-126, 2004. 250. Farnham SB, Cookson MS, Alberts G, Smith, Jr. JA, Chang SS. Long-term benefit of radical cystectomy in the elderly patient with

significant co-morbidities. Urol Onc 22:178-181, 2004. 251. Herrell SD, Smith JA Jr. Laparoscopic and robotic radical prostatectomy: What are the real advantages? BJU Int 95:3-9, 2005. 252. Smith JA Jr, Herrell SD. Robotic-assisted laparoscopic prostatectomy: do minimally invasive approaches offer significant

advantages? J Clin Onc 23:8170-8175, 2005. 253. Chang SS, Benson MC, Campbell SC, Crook J, Dreicer R, Evans CP, Hall MC, Higano C, Kelly WK, Sartor O, Smith JA Jr.

Society of Urologic Oncology, Shaumberg, Il. Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma. Cancer 103:11-21, 2005.

254. Webster TM, Herrell SD, Chang SS, Cookson MS, Baumgartner RG, Anderson LW, Smith JA Jr. Robotic assisted laparoscopic

radical prostatectomy versus retropubic radical prostatectomy: A prospective assessment of postoperative pain. J Urol 174:912-914, 2005.

255. Herrell SD, Smith JA Jr. Robotic-assisted laparoscopic prostatectomy: What is the learning curve? Urol 66:105-107, 2005. 256. Chang SS, Ivey B, Smith JA, Roth BJ, Cookson. Performance-enhancing supplement use in patients with testicular cancer. Urol

66:242-245, 2005. 257. Smith, JA. Integration of robotic radical prostatectomy into a practice of common open surgery procedures. Urologicke Listy 3:5-

11, 2005. 258. Smith, JA. Surgical treatment of carcinoma of the prostate. Business Briefing: U.S. Kidney and Urological Disease. p 69-71, 2005. 259. Smith JA, Chang SS, Keane TE, McKnight D, Gee W. Androgen deprivation. Research, results and reimbursement.

Contemporary Urol. 31-47, June 2005. 260. Smith JA. Surgical treatment of bladder cancer. Why is it underutilized? Editorial Cancer 104:1563-1566, 2005.


261. Smith JA, Cookson MS, Hall MC, Keane TE, Pruthi RS. Symposium: When PSA levels rise after prostatectomy. Patient Care

December:15-26, 2005. 262. Farnham S, Webster TM, Herrell SD, Smith JA Jr. Intraoperative blood loss and transfusion requirements for robotic-assisted

prostatectomy versus radical retropubic prostatectomy. Urol 67:360-363, 2006. 263. Smith JA Jr. Radical prostatectomy-which patients benefit most from surgery? J Urol 176:437, 2006. 264. Nelson BA, Chang SS, Cookson MS, Smith JA. Morbidity and efficacy of genitofemoral nerve grafts with radical retropubic

prostatectomy. Urol 67:789-792, 2006. 265. Girasole C, Cookson MS, Putzi MJ, Chang SS, Smith JA, Wells N, Oppenheimer JR, Shappell SB. Significance of atypical and

suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: Implications for cancer detection and biopsy strategy. J Urol 175:929-933, 2006.

266. Crawford ED, Wilson SS, McConnell JK, Slawin KM, Lieber MC, Smith JA, Meehan AG, Bautista OM, Nobel WR, Kusek JW,

Nyberg LM, Roehrborn CG, MTOPS Research Group. Baseline factors as predictors of clinical progression of benign prostate hyperplasia in men treated with placebo. J Urol 175:1422-1426, 2006.

267. Hassan JM, Cookson MS, Smith JA, Chang SS. Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol

175:2054-2057, 2006. 268. Chang SS, Smith JA, Herrell SD, Cookson MS. Assessing urinary diversion experience in urologic residency programsBAre we

adequately training the next generation? J Urol 176:691-693, 2006. 269. Kaurman RM, Smith JA Jr, Baumgartner RG, Wells N, Chang SS, Herrell SD, Cookson MS. BJU 97:473-475, 2006. 270. Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA Jr, Cookson MS. Tumour volume is an independent predictor

of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU . 97:1169-1172, 2006.

271. Girasole C, Cookson MS, Smith JA Jr, Ivey BS, Roth BJ, Chang SS. Sperm banking: Use and outcomes in patients treated for

testicular cancer. BJU 99:33-36, 2006. 272. Jung C, Cookson MS, Chang SS, Smith JA Jr, Dietrich MS, Teng M. Toxicity following high-dose salvage radiotherapy after

radical prostatectomy. BJU 99:529-533, 2006. 273. Nelson B, Kaufman MR, Broughton G, Cookson MS, Chang SS, Herrell SD, Baumgartner, RG, Smith JA Jr., Comparison of length

of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy. J Urol 177:929-931, 2007.

274. Kaufman MR, Baumgartner RG, Anderson LW, Smith JA Jr, Chang SS, Herrell SD, Cookson MS. The evidence-based pathway for

peri-operative management of open and robotically assisted laparoscopic radical prostatectomy. BJU 99:1103-1108, 2007. 275. Smith JA Jr. Words of wisdom review. European Urology 51:852-853, 2007. 276. Fowke JH, Motley SS, Wills M, Cookson MS, Concepcion RS, Eckstein CW, Chang SS, Smith JA Jr., Prostate volume modifies the

association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia. Cancer Causes & Control 18:375-384, 2007.

277. Lowrance W, Chang SS, Cokson MS, Clark PE, Smith JA Jr. Assessing retroperitoneal lymphadenectomy experience in US

urologic residency programs. J Urol. 178:500-503, 2007. 278. Fowke, JH, Motley, SS., Cookson, MS, Concepcion, R., Chang, SS., Wills, ML, Smith, JA. The association between body size,

prostate volume, and prostate-specific antigen. Prostate Cancer and Prostatic Diseases 10:137-142, 2007. BOOK CHAPTERS


1. Santen RH, Smith JA Jr, Warner B: The use of superagonist analogs of gonadotropin releasing hormone as treatment of human prostatic carcinoma. In: Vickery BH, Nestor JJ Jr, Hafez ESE (eds). LHRH and Its Analogs-A New Class of Contraceptive and Therapeutic Agents. Lancaster, MTP Press, 1983.

2. Smith JA Jr: Effect of laser therapy on tumor recurrence. In: Applications of Lasers and Electronics. Boston, Laser Institute of

America, 1984. 3. Smith JA Jr: Influence of pelvic irradiation in patients with pelvic lymph node metastasis from prostate cancer. In: Denis L,

Murphy GP (eds). Controlled Clinical Trials in Urologic Oncology. New York, Raven Press, 1984. 4. Smith JA Jr: LHRH agonists in prostatic cancer. In: Ratliff TL, Catalona WJ (eds). Urologic Oncology. New York, Martinus

Nijhoff Publishers, 1984, p 311-317. 5. Smith JA Jr, Crawford ED: Southwest Oncology Group experience with randomized trends for bladder cancer. In: Denis L,

Murphy GP (eds). Clinical Trials in Urologic Oncology. New York, Raven Press, 1984, p 249-254. 6. Smith JA Jr: Clinical application of LHRH analog therapy in patients with metastatic carcinoma of the prostate. In: Torungawa HA

(ed). International Perspectives in Chemotherapy. Tokyo, 1985. 7. Smith JA Jr: Clinical application of LHRH analog therapy in patients with metastatic carcinoma of the prostate. New Hormonal

Treatments for Prostate Cancer: Current Status and New Developments with Emphasis on the LHRH Analogues. Proceedings of a workshop held at the 14th International Congress of Chemotherapy, Kyoto, 1985, pg. 9-12.

8. Smith JA Jr: Clinical experience with LHRH treatment of prostate cancer. In: Schroeder FH, Richards B (eds). Theraputic

Principles in the Management of Prostatic Cancer. New York, Liss, 1985. 9. Smith JA Jr, Dixon JA: Tissue effects of lasers in urology. In: Smith JA Jr (ed). Lasers in Urologic Surgery. Chicago, Year Book

Medical Publishers, 1985. 10. Smith JA Jr, Middleton RG: Bladder cancer. In: Smith JA Jr (ed). Lasers In Urologic Surgery. Chicago, Year Book Medical

Publishers, 1985. 11. Smith JA Jr: Clinical application of LHRH therapy. In: Garnick MB (ed). New Hormonal Treatments for Prostate Cancer. Tokyo,

Tokyo Press, 1986, p 9-17. 12. Smith JA Jr: Laser treatment of bladder cancer. In: Crawford ED (ed). Urology Grand Rounds. Chicago, Sieber and McIntyre,

1986. 13. Smith JA Jr: LHRH analog therapy in patients with metastatic carcinoma of the prostate. In: Garnick MB (ed). New Hormonal

Treatments for Prostate Cancer: Current Status and New Developments. Tokyo, University of Tokyo Press, 1986. 14. Smith JA Jr: Urologic laser surgery. In: Kaufmann JJ (ed). Current Urology Therapy. Philadelphia, WB Saunders, 1986, p 296-

308. 15. Garnick MB, Lipton A, Max DT, Smith JA Jr: Trials with leuprolide in treatment of cancer. In: Vickery BH (ed). New Methods of

Cancer Therapy. Lancaster, Falcon House, 1987. 16. Smith JA Jr: Application of laser energy in urologic surgery. In: White R, Palmer JM (eds). New Techniques in Urology. New

York, Futura, 1987. 17. Smith JA Jr: Lasers in urology. In: Grayhack JT, Howards SS, Duckett JW (eds). Adult and Pediatric Urology. Chicago, Year

Book Medical Publishers, 1987. 18. Smith JA Jr: Management of condyloma acuminata. In: Resnick MI, Kursh ED (eds). Current Therapy in Genito-Urinary

Surgery. Philadelphia, Decker, 1987. 19. Smith JA Jr: Techniques of phototherapy in urology. In: Fuller TA (ed). Surgical Techniques Using Lasers. Collamore, 1987. 20. Smith JA Jr: Total androgen suppression in prostatic cancer. In: Rattiff TL, Catalona WJ (eds). Urologic Oncology. Boston,

Martinus Nijoff Publishers, 1987.


21. Smith JA Jr: Urologic laser surgery. In: Dixon JA (ed). Surgical Applications of Lasers. Chicago, Year Book Medical Publishers,

1987. 22. Smith JA Jr, Datz F: Interpretation of the equivocal bone scan. In: Paulson DF (ed). Problems in Urology. Philadelphia,

Lippincott, 1987. 23. Benson RC, Stein BS, Smith JA Jr: Urologic laser surgery. In: Karaffin L, Kendall R (eds). Urology Surgery. Woodbury, CT,

Practice of Surgery Ltd., 1988, Chapter 28, Volume 2, p 1-37. 24. Smith JA Jr: Evolving concepts in treatment of invasive bladder cancer. In: Murphy GP (ed). Theraputic Progress in Urologic

Cancers. New York, Liss, 1988. 25. Smith JA Jr: Indications for adjuvant treatment in urologic surgery. In: Recent Advances in Urology. Beijing, China Academic

Publishers, 1988. 26. Smith JA Jr: Local recurrence of bladder cancer. Am Urol Assoc Update 6:12-13, 1988. 27. Smith JA Jr: Radical retropubic prostatectomy for localized carcinoma of the prostate. In: Current Trends and Controversies in the

Treatment of Prostate Cancer. Toronto, MES Publishers, 1988. 28. Smith JA Jr: Treatment of localized prostate cancer. In: Hahn LB (ed). New Concepts in the Management of Prostate Cancer.

New York, L.M.R. Publishers, 1988. 29. Smith JA Jr: Treatment of invasive bladder cancer. In: Smith JA (ed). Lasers in Urologic Surgery. Chicago, Year Book Medical

Publishers, 1988. 30. Smith JA Jr: Update on laser technology. In: Fuchs GJ (ed). Hospital Medical Review. Los Angeles, 1988. 31. Lamm DL, Crissmann J, Blumenstein B, Crawford ED, Montie J, Scardino PT, Smith JA Jr: BCG in superficial bladder cancer. In:

Treatment of Superficial Bladder Cancer. New York, Liss, 1989. 32. Smith JA Jr: Combined pre-operative radiotherapy and surgery for bladder cancer. In: Carlton CE Jr, Scardino PT (eds).

Controversies in Urologic Management. Philadelphia, Saunders, 1989. 33. Smith JA Jr: Complications of laser surgery. In: Smith RB, Ehrlich RM (eds). Complications in Urologic Surgery. Philadelphia,

Saunders, 1989, p 629-637. 34. Smith JA Jr: Current concepts in laser treatment of bladder cancer. Murphy GP, Khoury S (eds). Therapeutic Progress in

Urological Cancers. Alan R. Liss, Inc., 1989, p 463-471. 35. Smith JA Jr: Indications for laser phototherapy. In: Marshall FF (ed). Operative Urology. Philadelphia, WB Saunders, 1989. 36. Smith JA Jr: Laser treatment of bladder cancer. In: Karafin L, Kendal R (eds). Practice of Urology. Hagestown, Harper and Row,

l989. 37. Smith JA Jr: Malignant tumors of the urogenital tract. In: Rakel RE (ed). Conn's Current Therapy. Philadelphia, WB Saunders,

1989, p 638-645. 38. Smith JA Jr: Role of lymphadenectomy for carcinoma of the prostate. In: Douglas E, Whitehead (eds). Current Operative

Urology. Philadelphia, Lippencott, 1989, p 190-199. 39. Smith JA Jr, Scardino PT, Resnick M: The National Institutes of Health sponsored ultrasound network. Background, objectives and

methods. In: Karr JP (ed). Diagnostic Ultrasound of the Prostate. Washington, D.C., National Cancer Institute, 1989. 40. Smith JA Jr, Scardino PT, Resnick M: The National Institutes of Health Sponsored Ultrasound Network. Clinical aspects of

prostate cancer. In: Catalona WJ, Coffey DS, Karr JP (eds). Assessment of New Diagnostic and Management Procedures. New York, Elsevier, 1989, p l00-104.


41. Crawford ED, Smith JA Jr, Soloway MS, Lange PH, Lynch DF, Bracken RB, Bertagria C: Treatment of stage D2 prostate cancer with leuprolide and anandron compared to leuprolide and placebo. Recent Advances in Urologic Cancer, Diagnosis, and Treatment. Paris, 1990, p 263-268.

42. Smith JA Jr: Carcinoma of the bladder. In: Crawford ED, Das S (eds). Current Genitourinary Cancer Surgery. Philadelphia, Lea

and Febiger, 1990. 43. Smith JA Jr: Endourologic destruction of urologic malignancies. In: Hulbert JH (ed). Atlas of Urology. Chicago, Year Book

Medical Publishers, p 229-235, 1990. 44. Smith JA Jr: New treatments for urologic diseases. In: Nyhus LM (ed). Surgery Annual. Norwolk, Apppleton Century Croft,

1990. 45. Smith JA Jr: Radical surgery for stage A1 prostate cancer: Is it indicated? In: Olsson C (ed). Controversies in the Management of

Prostate Cancer. Philadelphia, Co. Med. Communications Publishers, 1990. 46. Smith JA Jr: The American experience with laser surgery. In: Jensen DM and Brunetaud JM (eds). Medical Laser Endoscopy.

Kluwer Academic Publishers, Boston, 1990, p 257-268. 47. Smith JA Jr: Preoperative irradiation and cystectomy for bladder cancer. In: Whitehead ED (ed). Current Operative Urology.

Lippincott, Philadelphia, 1991, p 220-228. 48. Smith JA Jr: Urologic laser surgery. In: Walsh PC, Retick AB, Stamey TA, Vaughan ED Jr (eds). Campbell's Urology.

Philadelphia, WB Saunders, p 2923-2942, 1991. 49. Smith JA Jr: Laser treatment of urologic cancer. In: Gillenwater J, Grayhack HJ, Howards ST, Duckett JW (eds). Adult and

Pediatric Urology. Chicago, Mosby Year Book, 1991, p 357-371. 50. Smith JA Jr: Localized carcinoma of the prostate. In: Stein BS, Smith Jr JA, Caldamone T (eds). Practice of Urology. New York,

Norton Medical Publishers, 1991, Vol. 2, Chapter 10, p 1-16. 51. Smith JA Jr: Treatment of bladder cancer. In: Glenn JF, Graham SD (eds). Urologic Surgery. Philadelphia, Lippincott, 1991, p

422-432. 52. Hernandez AD, Smith JA Jr: Ultrasound in Urology. In: Smith JA Jr (ed). HighTech Urology: Technologic Innovations and Their

Clinical Applications. Philadelphia, WB Saunders, 1992, p 97-132. 53. Smith JA Jr: Surgery of the prostate and seminal vesicles. Special Comment. In: Fowler JE (ed). Mastery of Surgery. New York,

Little Brown and Company, 1992, p 402-403. 54. Smith JA Jr: Urologic Laser Surgery. Tissue effects and treatment of the urethra. In: Merkle W, Haupt G (eds). Moderne

Methoden der Sonographie und Lasertherapie in der Urologie. Cloppenburg, Biermann Verlag GmbH, 1992, p 136-143. 55. Smith JA Jr: Laser treatment of bladder cancer. In: Hanno PH, Siedman JP (eds). Current Urologic Therapy. Philadelphia, WB

Saunders, p 342-344, 1993. 56. Smith JA Jr: Treatment of stage A carcinoma of the prostate. In: Hanno PH, Siedman JP (eds). Current Urologic Therapy.

Philadelphia, WB Saunders, p 377-380, 1993. 57. Smith JA Jr: Contemporary Issues in Laser Urologic Surgery. AUA Update Series, 1993. 58. Smith JA Jr: Prognostic value of PSA changes in patients with metastatic carcinoma of the prostate. In: Murphy G, Khoury S,

Chatelain C, and Denis L (eds). Recent Advances in Urological Cancer Diagnosis and Treatment. Scientific Communication International, Jersey Channel Islands, p 227-230, 1993.

59. Somers WJ, Badalament RA, York JP, Smith JA Jr, Woodworth BE, and Nesbitt JA: Urology: Diseases of the Genitourinary

System. In: Lawrence PF (ed). Essentials of Surgical Specialties. Williams and Wilkins, Baltimore, p 344-401, 1993. 60. Milam DF, Lindner RM, and Smith JA Jr: Ureteroscopic treatment of ureothelial malignancy. In: Kandell LB (ed). Textbook of

Ureterscopy. New York, Igaku-Shoin, p 139-151, 1993.


61. Smith JA Jr: Treatment of benign and malignant disease of the prostate. In: Smith JA Jr (ed). Lasers in Urologic Surgery.

Chicago, Mosby Year Book Medical Publishers, 1994, p 83-102. 62. Smith JA Jr. Prostate Cancer: Advanced stage treatment options. In: Gillenwater JY (ed) Family Urology. AFUD, Baltimore, p 6-

10, 1995. 63. Koch MO, Smith JA Jr: Management of Superficial bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WV, and Coffey DJ

(eds). Comprehensive Textbook of Genitourinary Oncology. Williams and Wilkins, Baltimore, p 405-415, 1996. 64. Smith JA Jr: Bladder cancer. In: Marshall FF (ed). Textbook of Operative Urology. WB Saunders Co, Philadelphia, p 6-37, 1996. 65. Smith JA Jr: Clinical relevance of methods for ablation of prostate tissue. In: Milam DF and Smith JA Jr (eds). Techniques for

Ablation of Benign and Malignant Prostate Tissue. Igaku-Shoin Medical Publishers, New York, p 1-13, 1996. 66. Smith JA Jr: Complications of urologic laser surgery. In: Carson CC III (ed). Complications of Interventional Techniques. Igaku-

Shoin Medical Publishers, New York, p 152-164, 1996. 67. Smith JA Jr: Current concepts in the treatment of cancer of the prostate. In: Vedeckis WV (ed). Hormones and Cancer.

Birkhauser Publishers, Boston, p. 379-394, 1996. 68. Smith JA Jr: Laser surgery for carcinoma of the bladder. In: Crawford ED and Das S (eds). Current Genitourinary Cancer

Surgery (2nd Edition). Lea and Feabiger, Inc., Philadelphia, p 229-234, 1996. 69. Smith JA Jr: Malignant tumors of the urogenital tract. In: Rakel RE (ed). Conn's Current Therapy. WB Saunders Co,

Philadelphia, 687-694, 1996. 70. Smith JA Jr: Selection of patients for radical prostatectomy. In: Middleton RG (ed). Medical and Surgical Management of

Prostate Cancer. Igaku-Shoin Medical Publishers, Inc., New York, NY, p1-11, 1996. 71. Koch MO, Smith JA Jr: Radical cystectomy in men. In: Montie JE (ed). Atlas of the Urologic Clinics of North America. WB

Saunders Co., Philadelphia, 23-37, 1996. 72. Smith JA Jr: Perioperative management of the patient undergoing radical prostatectomy. In: Resnick MI and Thompson IA (eds).

Surgery of the Prostate. Churchill Livingstone, London, p. 31-39, 1997. 73. Koch MO, Smith JA Jr: Surgical treatment of adrenal cancers. In: Lange PH, Scher H, Liebel S, and Raghavan D (eds). Principles

and Practice of Genitourinary Oncology. J. B. Lippincott, Philadelphia, p 993-1000, 1997. 74. Smith JA Jr, Brendler C: Ureteral and kidney transitional cell carcinoma. In: American Cancer Society (ed) American Joint

Committee on Cancer Manual for Staging of Cancer. Fifth Edition. Lippincott-Raven, Philadelphia, 1997. 75. Smith, JA Jr: Bowel stapling techniques for use in urologic reconstructive surgery. In: Hinman FA (ed) Atlas of Urologic Surgery.

WB Saunders Co. Philadelphia, p. 64-68, 1998. 76. Franke JJ, Smith JA Jr: Surgery of the ureter. In: Walsh PC, Stamey TA, Retik AB, and Vaughan ED Jr (eds). Campbell's

Urology. WB Saunders Co, Philadelphia, p 3062-3084, 1998. 77. Franke JJ, Smith JA, Jr.: Surgery of the ureter. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbells=s Study Guide.

W.B. Saunders Co., Philadelphia, p. 415-416, 1998. 78. Smith JA Jr: Radical retropubic prostatectomy. In Graham SD, Glen J (eds) Glenn=s Urologic Surgery. J. B. Lippincott Co.,

Philadelphia, p. 275-284, 1998. 79. Smith JA Jr: Perioperative management for radical prostatectomy. In Resnick MI, Thompson IM (eds) Surgery of the Prostate.

Churchill Livingstone Inc., New York, p. 31-39, 1998. 80. Koch MO, Smith JA, Miller D, Baumgartner R, Wells N: Perioperative management of radical prostatectomy: the impact of critical

care pathways. In Klein EI(ed) Management of Prostate Cancer. Humana Press, Totowa, New Jersey, 1999.


81. Hudson T, Cahill J, Bobine R, Hoisaeter PA, Mossman J, O=Hara D, Msith JA, Navarrette RV: Public education. In Prostate Cancer. Health Publication Ltd., Plymouth, England, p. 539-542, 1999.

82. Holzbeierlein JM, Smith JA, Jr.: Management of Superficial Ta/T1/TIS Bladder Cancer. Natural History and Surgical Management.

In Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Genitourinary Oncology. Lippincott Williams & Wilkins, Philadelphia, p. 384-394, 2000.

83. Holzbeierlein JM, Smith JA, Jr: Surgical management of noninvasive bladder cancer (stages T1/T1/CIS). In Loughlin KR (eds). Superficial Bladder Cancer, New Strategies in Diagnosis and Management. W. B. Saunders, Philadelphia, p. 15-24, 2000.

84. Pietrow PK, Smith JA Jr:Radical Prostatectomy: Patient Preparation. In Resnick MI, Thompson IM (eds). Advanced Therapy of

Prostate Disease. B. C. Decker, Inc., Hamilton, 2000. 85. Nau WH Jr, Milam DF, Roselli RJ, and Smith JA Jr: Principles of laser therapy. In: Narayan P (ed). Benign Prostatic Hyperplasia.

Churchill Livingstone, London, p. 221-229, 2000. 86. Smith JA Jr: Management of malignant diseases of the urogenital system. In: Edlich RF (ed). Advances in Medicine. ABI

Professional Publications, Arlington, VA, p. 515-522, 2000. 87. Smith JA Jr: Radical cystectomy and urinary reconstruction for bladder cancer: morbidity and mortality in a contemporary series.

In: Perry MC (ed). American Society of Clinical Oncology Educational Book. Lippincott Williams and Wilkins, Baltimore, p. 388-391, 2000.

88. Gelman J, Smith JA, Jr Duel BP: Urology: Disease of the genitourinary system. In: Lawrence PF (ed) Essentials of Surgical

Subspecialties, 2nd edition. Williams and Wilkins, Baltimore, p. 419-470, 2000. 89. Cookson MS, Gilbert WB, Smith JA Jr: Urology. In Townsend CM, Beauchamp RD, Evers BM, Mattox KL (eds). Textbook of

Surgery. W. B. Saunders, Philadelphia, p. 1649-1693. 2001. 90. Smith JA Jr: Surgical treatment of prostate cancer. In: Scaletscky R (ed) Textbook of Urology. Medical Publisher, Sao Paulo, in

press. 91. Streem SB, Franke JJ, Smith JA Jr: Management of upper urinary tract obstruction. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein

AJ (eds). Campbell's Urology. WB Saunders Co, Philadelphia, p 463-512, 2002. 92. Smith JA Jr, Milam DF, Smith ER Jr. Men=s health topics. In: Andreoli TE, Carpente CCJ, Griggs RC, Loscalzo J (eds). Cecil

Essentials of Medicine. 6th edition. WB Saunders Co, Philadelphia, p 665-680, 2004. 93. Alberts G, Chang SS, Smith, Jr. JA. Intravesical Chemotherapy in Approaches to Treatment and Prophylaxis of Bladder Cancer. In

Urothelial Tumors. Ed. Droller MJ, 2004. 94. Hassan JM, Chang SS, Cookson MS, Smith JA Jr. Prognosis and Management of Invasive Transitional Cell Carcinoma. In: Richie

JP, D=Amico AV (eds). Urologic Oncology Elsevier Saunders Philadelphia, 2005, p 338-357. 95. Pietrow PK, Cookson MS, Smith JA Jr.: Urology In Becker J (ed) Becker=s Essentials of Surgery. Elsevier Saunders Philadelphia,

2006. 96. Kaufman MR, Smith JA Jr.: Selection and Perioperative Management of Patients Undergoing Radical Cystectomy In: Schoenberg

MP, Lerner SP, Sternberg CN (eds) Textbook of Bladder Cancer. Ken, UK:Taylor & Francis Group, 2006. 97. Su L-M, Smith JA Jr: Laparoscopic and Robotic-Assisted Laparoscopic Radical Prostatectomy and Pelvic Lymphadenectomy. In:

Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh Urology. 9th Edition. WB Saunders Co, Philadelphia, p 2985-3006, 2007.

98. Smith JA Jr: Robotic Prostatectomy. In: Tewari AS, Smith, JA Jr (eds) Robotics in Urologic Surgery. Elsevier Medical Publishing

(in press for 2008).

curriculum vitae july 2007 joseph a. smith, … · - societe internationale d'urologie -...

Documents